Breast cancer incidence and overdiagnosis in Catalonia (Spain)
- PMID: 20682042
- PMCID: PMC2949650
- DOI: 10.1186/bcr2620
Breast cancer incidence and overdiagnosis in Catalonia (Spain)
Abstract
Introduction: Early detection of breast cancer (BC) with mammography may cause overdiagnosis and overtreatment, detecting tumors which would remain undiagnosed during a lifetime. The aims of this study were: first, to model invasive BC incidence trends in Catalonia (Spain) taking into account reproductive and screening data; and second, to quantify the extent of BC overdiagnosis.
Methods: We modeled the incidence of invasive BC using a Poisson regression model. Explanatory variables were: age at diagnosis and cohort characteristics (completed fertility rate, percentage of women that use mammography at age 50, and year of birth). This model also was used to estimate the background incidence in the absence of screening. We used a probabilistic model to estimate the expected BC incidence if women in the population used mammography as reported in health surveys. The difference between the observed and expected cumulative incidences provided an estimate of overdiagnosis.
Results: Incidence of invasive BC increased, especially in cohorts born from 1940 to 1955. The biggest increase was observed in these cohorts between the ages of 50 to 65 years, where the final BC incidence rates more than doubled the initial ones. Dissemination of mammography was significantly associated with BC incidence and overdiagnosis. Our estimates of overdiagnosis ranged from 0.4% to 46.6%, for women born around 1935 and 1950, respectively.
Conclusions: Our results support the existence of overdiagnosis in Catalonia attributed to mammography usage, and the limited malignant potential of some tumors may play an important role. Women should be better informed about this risk. Research should be oriented towards personalized screening and risk assessment tools.
Figures





Similar articles
-
Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.CMAJ. 2013 Jul 9;185(10):E492-8. doi: 10.1503/cmaj.121791. Epub 2013 Jun 10. CMAJ. 2013. PMID: 23754101 Free PMC article.
-
Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.Cancer Causes Control. 2010 Feb;21(2):275-82. doi: 10.1007/s10552-009-9459-z. Epub 2009 Nov 6. Cancer Causes Control. 2010. PMID: 19894130
-
Interpreting overdiagnosis estimates in population-based mammography screening.Epidemiol Rev. 2011;33(1):111-21. doi: 10.1093/epirev/mxr009. Epub 2011 Jun 27. Epidemiol Rev. 2011. PMID: 21709144 Free PMC article. Review.
-
Overdiagnosis of invasive breast cancer in population-based breast cancer screening: A short- and long-term perspective.Eur J Cancer. 2022 Sep;173:1-9. doi: 10.1016/j.ejca.2022.06.027. Epub 2022 Jul 12. Eur J Cancer. 2022. PMID: 35839596
-
Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.J Med Screen. 2012;19 Suppl 1:42-56. doi: 10.1258/jms.2012.012082. J Med Screen. 2012. PMID: 22972810 Review.
Cited by
-
Cost-effectiveness of early detection of breast cancer in Catalonia (Spain).BMC Cancer. 2011 May 23;11:192. doi: 10.1186/1471-2407-11-192. BMC Cancer. 2011. PMID: 21605383 Free PMC article.
-
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.BMJ. 2015 Jan 7;350:g7773. doi: 10.1136/bmj.g7773. BMJ. 2015. PMID: 25569206 Free PMC article.
-
Overdiagnosis: epidemiologic concepts and estimation.Epidemiol Health. 2015 Feb 10;37:e2015004. doi: 10.4178/epih/e2015004. eCollection 2015. Epidemiol Health. 2015. PMID: 25824531 Free PMC article.
-
The fluctuating incidence, improved survival of patients with breast cancer, and disparities by age, race, and socioeconomic status by decade, 1981-2010.Cancer Manag Res. 2018 Oct 30;10:4899-4914. doi: 10.2147/CMAR.S173099. eCollection 2018. Cancer Manag Res. 2018. PMID: 30464592 Free PMC article.
-
Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain.PLoS One. 2012;7(1):e30157. doi: 10.1371/journal.pone.0030157. Epub 2012 Jan 17. PLoS One. 2012. PMID: 22272292 Free PMC article.
References
-
- Kelsey J, Gammon M, John E. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15:36–47. - PubMed
-
- van den Brandt P, Spiegelman D, Yaun S, Adami H, Beeson L, Folsom A, Fraser G, Goldbohm R, Graham S, Kushi L, Marshall JR, Miller A, Rohan T, Smith-Warner S, Speizer F, Willett WC, Wolk A, Hunter DJ. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152:514–527. doi: 10.1093/aje/152.6.514. - DOI - PubMed
-
- Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M, Jackson R, Beresford S, Howard B, Johnson K, Kotchen J, Ockene J. for the Women's Health Initiative Investigators WG. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333. doi: 10.1001/jama.288.3.321. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical